EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 6-Jun-2026 02:15 ET (6-Jun-2026 06:15 GMT/UTC)

A natural molecule present in the human body protects against the flu, Fisabio study reveals

Universidad Miguel Hernandez de Elche
Peer-Reviewed Publication

A study led by Fisabio (Spain) has characterized a previously undescribed mechanism of action that could be relevant for the development of new antiviral strategies for influenza and further respiratory viruses.

Journal: Proceedings of the National Academy of Sciences
Funder: Agència Valenciana de la Innovació, European Regional Development Fund, Ministerio de Economía y Competitividad

Ochsner hosts no-cost Iberville Parish health fair to promote cancer awareness and prevention

Ochsner Health System
Business Announcement

The event connected community members with local providers for health screenings, education and prevention resources.

Long-term durability of acoramidis efficacy in transthyretin amyloid cardiomyopathy

JAMA Network
Peer-Reviewed Publication

About The Study: In this open-label extension of the ATTRibute-CM randomized clinical trial, early and continuous acoramidis treatment resulted in sustained incremental reductions in all-cause mortality, cardiovascular-related mortality, and first cardiovascular hospitalization through month 54. These findings support the importance of early and continuous long-term treatment with acoramidis in transthyretin amyloid cardiomyopathy (ATTR-CM).

Journal: JAMA Cardiology

Bullying and peer victimization can trigger trauma symptoms in children, study finds

University of Florida
Peer-Reviewed Publication

Researchers found more than 40% of elementary school children who experienced bullying showed trauma symptoms, highlighting a major child mental health concern.

Journal: Journal of Clinical Child & Adolescent Psychology

New $20M effort aims to address critical gaps in care for people with single ventricle heart disease

American Heart Association
Grant and Award Announcement

The American Heart Association and Additional Ventures, a research foundation working toward a cure for single ventricle heart disease, have committed a combined $20M to advance a coordinated, collaborative approach to improving the ability to predict, prevent and treat health complications in people living with Fontan circulation.

Stroke: Promising GPVI inhibitor takes an important step toward clinical development

University of Würzburg
Business Announcement

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601. University Hospital Würzburg has supported the development of this novel compound from the outset. EMA601 specifically targets the platelet surface receptor glycoprotein VI (GPVI). Studies conducted in Würzburg showed that EMA601 very effectively blocks the GPVI signaling pathway, thereby preventing thrombosis and thrombo‑inflammatory disease processes without impairing essential blood coagulation. This makes EMA601 interesting for use in acute stroke.

New NIH-funded Johns Hopkins Medicine study finds switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

Johns Hopkins Medicine
Peer-Reviewed Publication

In a new Johns Hopkins Medicine study funded by the National Institutes of Health, researchers found adults with HIV who switched from protease inhibitors to integrase inhibitors were at increased risk of diabetes.

Journal: The Lancet HIV
Funder: National Institutes of Health

With help from AI, eye images offer window into cardiovascular risk

American College of Cardiology
Reports and Proceedings

A new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during eye exams demonstrated strong correlation with a standard cardiovascular risk assessment, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26). Researchers said using AI to screen for heart disease risk during routine eye exams could help more people become aware of their risk and facilitate referrals for preventative care.

Meeting: American College of Cardiology's Annual Scientific Session

Nanoparticles genetically modify several human cell types

University of Michigan
Peer-Reviewed Publication

In a demonstration that helps pave the way for gene therapies with fewer side effects, several human cell types were genetically modified with protein nanoparticles designed at University of Michigan Engineering and Michigan Medicine.

Journal: Advanced Materials
Funder: National Institutes of Health